Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Data Analyst The Opportunity: As a Data Analyst, you will be responsible for transforming operational and enterprise‑level data into strategic insights that drive mission success. You will call upon your experience in data analysis, visualization, and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
At EY, you’ll have the chance to build a career as unique as you are, with the global scale, support, inclusive culture and technology to become the best version of you. And we’re counting on your
This role requires the candidate to work on-site in Tokyo, Japan. Client Overview Our client is a global technology solutions provider specializing in Artificial Intelligence (AI), Cloud Computing, Data Engineering, and Digital Transformation (DX). The organization
This role requires the candidate to work on-site in Tokyo, Japan. Client Overview Our client is a global technology consulting organization specializing in Artificial Intelligence (AI), Digital Transformation (DX), enterprise technology consulting, and data-driven business transformation.